Risk factors associated with the antimicrobial resistance of staphylococci in canine pyoderma

Veterinary Microbiology

Volumn 150, Issue 3-4, 2011, Pages 302-308

  Huerta, Belén ^a   Maldonado, Alfonso ^a   Ginel, Pedro J ^a   Tarradas, Carmen ^a   Gómez Gascón, Lidia ^a   Astorga, Rafael J ^a   Luque, Inmaculada ^a  

^a UNIVERSITY OF CÓRDOBA   (Spain)

Author keywords

Antimicrobial susceptibility; Dog; Methicillin resistance; Pyoderma; Staphylococci

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; BACTERIAL ENZYME; BETA LACTAMASE; CEFADROXIL; CEFALEXIN; CEFALOTIN; CEFTIOFUR; CIPROFLOXACIN; CLINDAMYCIN; ENROFLOXACIN; GENTAMICIN; METICILLIN; OXACILLIN; RIFAMPICIN; TETRACYCLINE; VETERINARY DRUG;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; ARTICLE; BACTERIUM CULTURE; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATION; COAGULASE NEGATIVE STAPHYLOCOCCUS; CONTROLLED STUDY; DOG DISEASE; HABITAT; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MULTIDRUG RESISTANCE; NONHUMAN; PYODERMA; RECURRENT INFECTION; RISK FACTOR; SEX DIFFERENCE; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INTERMEDIUS; URBAN AREA;

ANIMALS; ANTI-BACTERIAL AGENTS; CEPHALOSPORINS; DOG DISEASES; DOGS; FEMALE; FLUOROQUINOLONES; MALE; METHICILLIN; PYODERMA; RISK FACTORS; STAPHYLOCOCCUS;

ANIMALIA; CANIS FAMILIARIS; STAPHYLOCOCCUS;

EID: 79955957096     PISSN: 03781135     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vetmic.2011.02.002     Document Type: Article

References (25)

1. Clinical and Laboratory Standards Institute (CLSI), 2008. Performance Standards for Antimicrobial Disk and Dilution Susceptibility Test for Bacteria Isolated from Animals: Approved Standard, third ed. M31-A3, vol. 28, no. 8.
2. Faires M.C., Gard S., Aucoin D., Weese J.S. Inducible clindamycin-resistance in methicillin-resistant Staphylococcus aureus and methicillin-resistant Staphylococcus pseudintermedius isolates from dogs and cats. Vet. Microbiol. 2009, 139:419-420.
3. Fazakerley J., Nuttall T., Sales D., Szhmidt V., Carter S.D., Hart C.A., McEwan N.A. Staphylococcal colonization of mucosal and lesion skin sites in atopic and healthy dogs. Vet. Dermatol. 2009, 20:179-184.
4. Fitzgerald J.R. The Staphylococcus intermedius group of bacterial pathogens: species re-classification, pathogenesis and the emergence of meticillin resistance. Vet. Dermatol. 2009, 20:490-495.
5. Futagawa-Saito K., Ba-Thein W., Fukuyasu T. High occurrence of multi-antimicrobial resistance in Staphylococcus intermedius isolates from healthy and diseased dogs and domesticated pigeons. Res. Vet. Sci. 2007, 83:336-339.
6. Ganière J.P., Médaille C., Limet A., Ruvoen N., André-Fontaine G. Antimicrobial activity of enrofloxacin against Staphylococcus intermedius strains isolated from canine pyodermas. Vet. Dermatol. 2001, 12:171-175.
7. Ganiere J.P., Medaille C., Mangion C. Antimicrobial drug susceptibility of Staphylococcus intermedius clinical isolates from canine pyoderma. J. Vet. Med. B: Infect. Dis. Vet. Public Health 2005, 52:25-31.
8. Griffeth G.C., Morris D.O., Abraham J.L., Shofer F.S., Rankin S.C. Screening for skin carriage of methicillin-resistant coagulase-positive staphylococci and Staphylococcus schleiferi in dogs with healthy and inflamed skin. Vet. Dermatol. 2008, 19:142-149.
9. Guardabassi L., Loeber M.E., Jacobson A. Transmission of multiple antimicrobial-resistant Staphylococcus intermedius between dogs affected by deep pyoderma and their owners. Vet. Microbiol. 2004, 14:23-27.
10. Hartmann F.A., White D.G., West S.E., Walker R.D., Deboer D.J. Molecular characterization of Staphylococcus intermedius carriage by healthy dogs and comparison of antimicrobial susceptibility patterns to isolates from dogs with pyoderma. Vet. Microbiol. 2005, 108:119-131.
11. Hauschild T., Wójcik A. Species distribution and properties of staphylococci from canine dermatitis. Vet. Sci. 2007, 82:1-6.
12. Holm B.R., Petersson U., Mörner A., Bergström K., Franklin A., Greko C. Antimicrobial resistance in staphylococci from canine pyoderma: a prospective study of first-time and recurrent cases in Sweden. Vet. Rec. 2002, 151:600-605.
13. Kadlec K., Schwarz S., Perreten V., Andersson U.G., Finn M., Greko C., Moodley A., Kania S.A., Frank L.A., Bemis D.A., Franco A., Iurescia M., Battisti A., Duim B., Wagenaar J.A., van Duijkeren E., Weese J.S., Fitzgerald J.R., Rossano A., Guardabassi L. Molecular analysis of methicillin-resistant Staphylococcus pseudintermedius of feline origin from different European countries and North America. J. Antimicrob. Chemother. 2010, 65:1826-1828.
14. Levin T.P., Suh B., Axelrod P., Truant A.L., Fekete T. Potential clindamycin resistance in clindamycin-susceptible, erythromycin-resistant Staphylococcus aureus: report of a clinical failure. Antimicrob. Agents Chemother. 2005, 49:1222-1224.
15. Loeffler A., Linek M., Moodley A., Guardabassi L., Sung J.M., Winkler M., Weiss R., Lloyd D.H. First report of multiresistant, mecA-positive Staphylococcus intermedius in Europe: 12 cases from a veterinary dermatology referral clinic in Germany. Vet. Dermatol. 2007, 18:412-421.
16. Matsuhashi M., Song M.D., Ishino F., Wachi M., Doi M., Inoue M., Ubukata K., Yamashita N., Konno M. Molecular cloning of the gene of a penicillin-binding protein supposed to cause high resistance to beta-lactam antibiotics in Staphylococcus aureus. J. Bacteriol. 1986, 167:975-980.
17. Morris D.O., Rook K.A., Shofer F.S., Rankin S.C. Screening of Staphylococcus aureus, Staphylococcus intermedius, and Staphylococcus schleiferi isolates obtained from small companion animals for antimicrobial resistance: a retrospective review of 749 isolates (2003-04). Vet. Dermatol. 2006, 17:332-337.
18. Petersen A.D., Walker R.D., Bowman M.M., Schott H.C., Rosser E.J. Frequency of isolation and antimicrobial susceptibility patterns of Staphylococcus intermedius and Pseudomonas aeruginosa isolates from canine skin and ear samples over a 6-year period (1992-1997). J. Am. Anim. Hosp. Assoc. 2002, 38:407-413.
19. Rantala M., Lahti E., Kuhalampi J., Pesonen S., Järvinen A.-K., Saijonmaa-Koulumies L., Honkanen-Buzalski T. Antimicrobial resistance in Staphylococcus spp., Escherichia coli and Enterococcus spp. in dogs given antibiotics for chronic dermatological disorders, compared with non-treated control dogs. Acta Vet. Scand. 2004, 45:37-45.
20. Rich M., Deighton L., Roberts L. Clindamycin-resistance in methicillin-resistant Staphylococcus aureus isolated from animals. Vet. Microbiol. 2005, 20:237-240.
21. Sasaki T., Kikuchi K., Tanaka Y., Takahashi N., Kamata S., Hiramatsu K. Reclassification of phenotypically identified Staphylococcus intermedius strains. J. Clin. Microbiol. 2007, 45:2770-2778.
22. Shimizu A., Wakita Y., Nagase S., Okabe M., Koji T., Hayashi T., Nagase N., Sasaki A., Kawano J., Yamashita K., Takagi M. Antimicrobial susceptibility of Staphylococcus intermedius isolated from healthy and diseased dogs. J. Vet. Med. Sci. 2001, 63:357-360.
23. Vanni M., Tognetti R., Pretti C., Crema F., Soldani G., Meucci V., Intorre L. Antimicrobial susceptibility of Staphylococcus intermedius and Staphylococcus schleiferi isolated from dogs. Vet. Sci. 2009, 87:192-195.
24. Yilmaz G., Aydin K., Iskender S., Caylan R., Koksal I. Detection and prevalence of inducible clindamycin resistance in staphylococci. J. Med. Microbiol. 2007, 56.
25. Zdovc I., Ocepek M., Pirs T., Krt B., Pinter L. Microbiological features of Staphylococcus schleiferi subsp. coagulans, isolated from dogs and possible misidentification with other canine coagulase-positive staphylococci. J. Vet. Med. B: Infect. Dis. Vet. Public Health 2004, 51:449-454.